News

28.03.25

Upcoming conferences

22.04.25

We are attending LSX World Congress

09.04.25

Amyl Therapeutics is one of the 10 startups selected to pitch at BioVaria

07.04.25

2025 AD/PD conference

26.03.25

Laborama 2025 in Brussels

18.03.25

Fire training

12.03.25

First year at the LégiaPark

27.02.25

Bio-Neuroscience

24.12.24

Merry Christmas from the Amyl Team

17.12.24

The Amyl Team – Who does what ?

04.11.24

Bio-Europe Fall in Stockholm

24.09.24

Team Building Event & Leadership Transition Announcement

05.07.24

1st International AL Amyloidosis meeting

05.03.24

2024 AD/PD conference

07.11.23

Amyl Therapeutics receives additional €5M funding to advance therapeutic platform

04.09.23

Amyl Team at the International Society on Amyloidosis (ISA) 2022

03.06.21

Amyl Therapeutics closes €18.3 million Series A financing to develop novel therapies for Amyloidosis